Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

17.19
Delayed Data
As of Jul 31
 +0.80 / +4.88%
Today’s Change
3.92
Today|||52-Week Range
17.42
+106.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues475.0K293.0K0.000.00
 
 
 
Depreciation And Amortization396.0K375.0K363.0K508.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----363.0K-508.0K
 
 
 
General Expenses14.7M17.3M21.1M22.5M
 
 
 
 
 
Research And Development10.0M12.0M15.6M16.1M
 
 
 
 
 
Total Operating Expenses15.1M17.7M21.5M23.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.7M-17.4M-21.5M-23.0M
 
 
 
 
 
Extraordinary Credit386.0K600.0K--0.00
 
 
 
Extraordinary Charge-10.0K-26.0K-511.0K-1.0M
 
 
 
 
 
Interest Expense On Debt374.0K377.0K378.0K372.0K
 
 
 
 
 
Other Expenses0.000.00-47.0K-29.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.6M-17.1M-22.3M-24.3M
 
 
 
 
 
Income Taxes0.000.00-1.1M0.00
 
 
Net Income-14.6M-17.1M-21.2M-24.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS67.2M78.9M87.0M95.7M
 
 
 
 
 
Shares To Calculate EPS Diluted67.2M78.9M87.0M95.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.22-$0.24-$0.25
 
 
 
 
 
EPS Diluted-$0.22-$0.22-$0.24-$0.25